<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05619952</url>
  </required_header>
  <id_info>
    <org_study_id>030-614292</org_study_id>
    <nct_id>NCT05619952</nct_id>
  </id_info>
  <brief_title>Postprandial Lipemia and Glycemia Following a High-Fat Meal</brief_title>
  <official_title>Acute Effects of White Button and Shiitake Mushroom Powder Supplementation on Postprandial Lipemia and Glycemia Following a High-Fat Meal</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>State University of New York at Buffalo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>State University of New York at Buffalo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this clinical trial is to determine the acute effects on postprandial lipemia and&#xD;
      glycemia by supplementing a high-fat meal with either white button (WB) or shiitake (SH)&#xD;
      mushroom powder in relatively healthy adults, aged 18 to 35.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 29, 2014</start_date>
  <completion_date type="Actual">June 1, 2022</completion_date>
  <primary_completion_date type="Actual">July 1, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Double-blind, randomized</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Postprandial Lipemia</measure>
    <time_frame>Baseline, up to 6 hours postprandial</time_frame>
    <description>Total cholesterol, LDL, HDL, triglycerides</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postprandial Glycemia</measure>
    <time_frame>Baseline, up to 6 hours postprandial</time_frame>
    <description>blood glucose</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Hypercholesterolemia</condition>
  <condition>Postprandial Hyperglycemia</condition>
  <condition>Lipid Disorder</condition>
  <arm_group>
    <arm_group_label>White Button Mushroom</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>368.5 grams of irradiated ground beef patty (80/20 lean mass to fat ratio) + 14 grams white button mushroom powder, and a Wegmans Food Market Brand Big Hawaiian bun</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Shiitake Mushroom</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>368.5 grams of irradiated ground beef patty (80/20 lean mass to fat ratio) + 14 grams Shiitake mushroom powder, and a Wegmans Food Market Brand Big Hawaiian bun</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>368.5 grams of irradiated ground beef patty (80/20 lean mass to fat ratio) and a Wegmans Food Market Brand Big Hawaiian bun.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Mushroom Powder</intervention_name>
    <description>Ground shiitake mushrooms or ground white button mushrooms</description>
    <arm_group_label>Shiitake Mushroom</arm_group_label>
    <arm_group_label>White Button Mushroom</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  generally healthy&#xD;
&#xD;
          -  non-diabetic&#xD;
&#xD;
          -  normal to mildly hypercholesterolemic (Total Cholesterol 200-239 mg/dL and LDL-C&#xD;
             130-159 mg/dL)&#xD;
&#xD;
          -  have BMI &lt;30 or BF% (men &lt;25%, women &lt;32%)&#xD;
&#xD;
          -  no known disease of the liver or gallbladder&#xD;
&#xD;
          -  no documented problems with fat metabolism&#xD;
&#xD;
          -  normal lipemic response to a lipid challenge&#xD;
&#xD;
          -  No known mushroom allergy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  diabetic&#xD;
&#xD;
          -  pregnant&#xD;
&#xD;
          -  BMI &gt;30&#xD;
&#xD;
          -  liver disease&#xD;
&#xD;
          -  gallbladder disease&#xD;
&#xD;
          -  mushroom allergy&#xD;
&#xD;
          -  lipid disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <link>
    <url>https://doi.org/10.14302/issn.2379-7835.ijn-23-4430</url>
    <description>Related Info</description>
  </link>
  <results_reference>
    <citation>Lillian A. Talal, Huipei Wang, Brian T. Wil-liams, Matthew J. Morris, Peter J. Horvath (2023) Acute Effects of White Button and Shiitake Mushroom Powder Supplementa-tion on Postprandial Lipemia and Glycemia Following a High-Fat Meal . International Journal of Nutrition - 7(2):42-56.</citation>
  </results_reference>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>November 9, 2022</study_first_submitted>
  <study_first_submitted_qc>November 9, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2022</study_first_posted>
  <last_update_submitted>March 23, 2023</last_update_submitted>
  <last_update_submitted_qc>March 23, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>State University of New York at Buffalo</investigator_affiliation>
    <investigator_full_name>Lillian A. Talal</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>mushroom</keyword>
  <keyword>lipid metabolism</keyword>
  <keyword>postprandial lipemia</keyword>
  <keyword>postprandial glycemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
    <mesh_term>Hyperglycemia</mesh_term>
    <mesh_term>Hyperlipidemias</mesh_term>
    <mesh_term>Lipid Metabolism Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

